Thallium-201 scintigraphy was used to evaluate chemotherapeutic respon
se in a case of rhabdomyosarcoma treated with epirubicin. A scintigrap
hic semiquantitative index of tumor viability was correlated with MRI
and clinical assessment. Both imaging studies were performed before th
erapy and after treatment involving a cumulative dose of 640 mg/m2 of
epirubicin. A very good inverse correlation was observed between Tl-20
1 uptake and tumor necrosis evaluated by MRI, leading to the conclusio
n that sequential Tl-201 scintigraphy may have a role not only in deli
neating the extent of the tumor, but in objectively assessing tumor re
sponse to therapeutic interventions. The proposed scintigraphic method
is much simpler to perform and less expensive than MRI-derived semiqu
antitative measurement of tumor necrosis.